Engineered Nanoparticles for Drug Delivery in Cancer Therapy
The DOI matches its Crossref record; 579 of the 579 references it cites were found in a registry or an index.
Abstract
In medicine, nanotechnology has sparked a rapidly growing interest as it promises to solve a number of issues associated with conventional therapeutic agents, including their poor water solubility (at least, for most anticancer drugs), lack of targeting capability, nonspecific distribution, systemic toxicity, and low therapeutic index. Over the past several decades, remarkable progress has been made in the development and application of engineered nanoparticles to treat cancer more effectively. For example, therapeutic agents have been integrated with nanoparticles engineered with optimal sizes, shapes, and surface properties to increase their solubility, prolong their circulation half‐life, improve their biodistribution, and reduce their immunogenicity. Nanoparticles and their payloads have also been favorably delivered into tumors by taking advantage of the pathophysiological conditions, such as the enhanced permeability and retention effect, and the spatial variations in the pH value. Additionally, targeting ligands (e.g., small organic molecules, peptides, antibodies, and nucleic acids) have been added to the surface of nanoparticles to specifically target cancerous cells through selective binding to the receptors overexpressed on their surface. Furthermore, it has been demonstrated that multiple types of therapeutic drugs and/or diagnostic agents (e.g., contrast agents) could be delivered through the same carrier to enable combination therapy with a potential to overcome multidrug resistance, and real‐time readout on the treatment efficacy. It is anticipated that precisely engineered nanoparticles will emerge as the next‐generation platform for cancer therapy and many other biomedical applications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
In the citing paper
“Vasculature plays an essential role in the growth and metastasis of malignant tumors [103].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
Citations
Cites
Items 401–579 of 579
Polyvalent Nucleic Acid Nanostructures
Cutler, J. I., Zhang, K., Zheng, D., Auyeung, E., Prigodich, A. E., & Mirkin, C. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja203375n · Cited by 180
Passirani, C., Barratt, G., Devissaguet, J.-P., & Labarre, D. (1998) · Pharmaceutical Research · doi:10.1023/a:1011930127562 · Cited by 179
Nanovector delivery of siRNA for cancer therapy
Shen, H., Sun, T., & Ferrari, M. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.22 · Cited by 176
Self-citationControlling and Switching the Morphology of Micellar Nanoparticles with Enzymes
Ku, T.-H., Chien, M.-P., Thompson, M. P., Sinkovits, R. S., Olson, N. H., Baker, T. S., & Gianneschi, N. C. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2004736 · Cited by 173
Angst, M. S., & Drover, D. R. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645120-00002 · Cited by 173
Colloidal Aggregation Affects the Efficacy of Anticancer Drugs in Cell Culture
Owen, S. C., Doak, A. K., Wassam, P., Shoichet, M. S., & Shoichet, B. K. (2012) · ACS Chemical Biology · doi:10.1021/cb300189b · Cited by 171
Polymerization of and within self-organized media
Hentze, H.-P., & Kaler, E. W. (2003) · Current Opinion in Colloid & Interface Science · doi:10.1016/s1359-0294(03)00018-9 · Cited by 170
Chen, K.-J., Chaung, E.-Y., Wey, S.-P., Lin, K.-J., Cheng, F., Lin, C.-C., Liu, H.-L., Tseng, H.-W., Liu, C.-P., Wei, M.-C., et al. (2014) · ACS Nano · doi:10.1021/nn501162x · Cited by 170
Lee, S.-W., Yun, M.-H., Jeong, S. W., In, C.-H., Kim, J.-Y., Seo, M.-H., Pai, C.-M., & Kim, S.-O. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.012 · Cited by 169
Cellular Dynamics of EGF Receptor–Targeted Synthetic Viruses
de Bruin, K., Ruthardt, N., von Gersdorff, K., Bausinger, R., Wagner, E., Ogris, M., & Bräuchle, C. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300176 · Cited by 168
Xiong, Q., Valero, V., Kau, V., Kau, S.-W., Taylor, S., Smith, T. L., Buzdar, A. U., Hortobagyi, G. N., & Theriault, R. L. (2001) · Cancer · doi:10.1002/1097-0142(20011115)92:10<2523::aid-cncr1603>3.0.co;2-6 · Cited by 166
Chitosan-dextran Sulfate Nanoparticles for Delivery of an Anti-angiogenesis Peptide
Chen, Y., Mohanraj, V. J., & Parkin, J. E. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02442596 · Cited by 166
A gel-membrane model of glomerular charge and size selectivity in series
Ohlson, M., Sörensson, J., & Haraldsson, B. S. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.3.f396 · Cited by 166
Lo, C.-L., Huang, C.-K., Lin, K.-M., & Hsiue, G. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.050 · Cited by 165
Further evidence to support the melanocytic origin of MDA-MB-435
Ellison, G. (2002) · Molecular Pathology · doi:10.1136/mp.55.5.294 · Cited by 164
Yin, L., Tang, H., Kim, K. H., Zheng, N., Song, Z., Gabrielson, N. P., Lu, H., & Cheng, J. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302820 · Cited by 164
Zhang, C., Pan, D., Luo, K., She, W., Guo, C., Yang, Y., & Gu, Z. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300601 · Cited by 163
pH-Induced Release from P2VP−PEO Block Copolymer Vesicles
Borchert, U., Lipprandt, U., Bilang, M., Kimpfler, A., Rank, A., Peschka-Süss, R., Schubert, R., Lindner, P., & Förster, S. (2006) · Langmuir · doi:10.1021/la060227t · Cited by 163
Ultrathin Zirconium Disulfide Nanodiscs
Jang, J.-T., Jeong, S., Seo, J.-W., Kim, M.-C., Sim, E., Oh, Y., Nam, S., Park, B., & Cheon, J. (2011) · Journal of the American Chemical Society · doi:10.1021/ja200400n · Cited by 163
Au, L., Zhang, Q., Cobley, C. M., Gidding, M., Schwartz, A. G., Chen, J., & Xia, Y. (2010) · ACS Nano · doi:10.1021/nn901392m · Cited by 162
Single‐Triggered Trimeric Prodrugs
Haba, K., Popkov, M., Shamis, M., Lerner, R. A., Barbas, C. F., & Shabat, D. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461657 · Cited by 161
Zuleger, S., & Lippold, B. C. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00596-8 · Cited by 160
Oishi, M., Hayashi, H., Iijima, M., & Nagasaki, Y. (2007) · Journal of Materials Chemistry · doi:10.1039/b706973a · Cited by 160
Mesoporous Silica Nanomaterial-Based Biotechnological and Biomedical Delivery Systems
Giri, S., Trewyn, B. G., & Lin, V. S. (2007) · Nanomedicine · doi:10.2217/17435889.2.1.99 · Cited by 159
Yang, J., Lee, J., Kang, J., Oh, S. J., Ko, H., Son, J., Lee, K., Suh, J., Huh, Y., & Haam, S. (2009) · Advanced Materials · doi:10.1002/adma.200900334 · Cited by 158
Gan, D., & Lyon, L. A. (2002) · Macromolecules · doi:10.1021/ma021186k · Cited by 155
Du, J., Sun, T., Song, W., Wu, J., & Wang, J. (2010) · Angewandte Chemie · doi:10.1002/ange.200907210 · Cited by 155
Self-citationJatzkewitz, H. (1955) · Zeitschrift für Naturforschung B · doi:10.1515/znb-1955-0106 · Cited by 154
Polyacetal−Doxorubicin Conjugates Designed for pH-Dependent Degradation
Tomlinson, R. D., Heller, J., Brocchini, S., & Duncan, R. (2003) · Bioconjugate Chemistry · doi:10.1021/bc030028a · Cited by 154
Hyaluronic acid–polyethyleneimine conjugate for target specific intracellular delivery of siRNA
Jiang, G., Park, K., Kim, J., Kim, K. S., Oh, E. J., Kang, H., Han, S., Oh, Y., Park, T. G., & Kwang Hahn, S. (2008) · Biopolymers · doi:10.1002/bip.20978 · Cited by 153
Tumor heterogeneity and its implication for drug delivery
Denison, T. A., & Bae, Y. H. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.014 · Cited by 150
Yang, Z., Liang, G., Ma, M., Gao, Y., & Xu, B. (2007) · Small · doi:10.1002/smll.200700015 · Cited by 149
Minai, L., Yeheskely‐Hayon, D., & Yelin, D. (2013) · Scientific Reports · doi:10.1038/srep02146 · Cited by 148
Remaut, K., Lucas, B., Braeckmans, K., Demeester, J., & Smedt, S. C. D. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.029 · Cited by 146
Damascelli, B., Cant�, G., Mattavelli, F., Tamplenizza, P., Bidoli, P., Leo, E., Dosio, F., Cerrotta, A. M., Di Tolla, G., Frigerio, L. F., et al. (2001) · Cancer · doi:10.1002/1097-0142(20011115)92:10<2592::aid-cncr1612>3.0.co;2-4 · Cited by 146
Nori, A., Jensen, K. D., Tijerina, M., Kopečková, P., & Kopec̆ek, J. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0255900 · Cited by 145
Clerc, S., & Barenholz, Y. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00214-6 · Cited by 145
Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors
Rivkin, I., Cohen, K., Koffler, J. Y., Melikhov, D., Peer, D., & Margalit, R. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.067 · Cited by 144
Proteolysis: A Biological Process Adapted in Drug Delivery, Therapy, and Imaging
Law, B., & Tung, C. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800500a · Cited by 142
Schluep, T., Cheng, J., Khin, K. T., & Davis, M. E. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0091-7 · Cited by 142
Passirani, C., BARRATT, G. M., Devissaguet, J., & Labarre, D. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)01175-2 · Cited by 141
Chain‐Shattering Polymeric Therapeutics with On‐Demand Drug‐Release Capability
Zhang, Y., Yin, Q., Yin, L., Ma, L., Tang, L., & Cheng, J. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201300497 · Cited by 141
Self-citationNanoparticles with targeting, triggered release, and imaging functionality for cancer applications
Loomis, K. H., McNeeley, K. M., & Bellamkonda, R. V. (2010) · Soft Matter · doi:10.1039/c0sm00534g · Cited by 140
Tong, L., Cobley, C. M., Chen, J., Younan Xia, A., & Cheng, J. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000440 · Cited by 138
Docetaxel Nanotechnology in Anticancer Therapy
Zhao, P., & Astruc, D. (2012) · ChemMedChem · doi:10.1002/cmdc.201200052 · Cited by 136
Imaging Viral Behavior in Mammalian Cells with Self‐Assembled Capsid–Quantum‐Dot Hybrid Particles
Li, F., Zhang, Z., Peng, J., Cui, Z., Pang, D., Li, K., Wei, H., Zhou, Y., Wen, J., & Zhang, X. (2009) · Small · doi:10.1002/smll.200801303 · Cited by 136
Chung, M., Chen, K., Liang, H., Liao, Z., Chia, W., Younan Xia, A., & Sung, H. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201205482 · Cited by 134
Mesoporosity and Functional Group Dependent Endocytosis and Cytotoxicity of Silica Nanomaterials
Tao, Z., Toms, B. B., Goodisman, J., & Asefa, T. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900276u · Cited by 134
Khorsand, B., Lapointe, G., Brett, C. L., & Oh, J. K. (2013) · Biomacromolecules · doi:10.1021/bm4004805 · Cited by 134
MATSUMOTO, K., YAMAMOTO, T., KAMATA, R., & MAEDA, H. (1984) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a134892 · Cited by 133
Minko, T., Kopečková, P., & Kopeček, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018959029186 · Cited by 131
Fattal, E., & Bochot, A. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.06.011 · Cited by 131
Liposomal daunorubicin as treatment for Kaposi’s sarcoma
Dittmer, D. P., & Petre, C. E. (2020) · PubMed · doi:10.17615/wyf0-9n94 · Cited by 131
Choi, S., Zhang, Y. S., & Younan Xia, A. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200900763 · Cited by 129
Self-citationŞanlioğlu, A. D., Dirice, E., Aydın, Ç., Erin, N., Köksoy, S., & Şanlıoğlu, S. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-54 · Cited by 129
Antibody-targeted Polymer–doxorubicin Conjugates with pH-controlled Activation
Ulbrich, K., Etrych, T., Chytil, P., Jelínková, M., & Říhová, B. (2004) · Journal of Drug Targeting · doi:10.1080/10611860400011869 · Cited by 128
Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients
La-Beck, N. M., Zamboni, B. A., Gabizón, A., Schmeeda, H., Amantea, M., Gehrig, P. A., & Zamboni, W. C. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1664-2 · Cited by 125
Antitumor Activity of β-Cyclodextrin Polymer−Camptothecin Conjugates
Cheng, J., Khin, K. T., & Davis, M. E. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049966y · Cited by 123
Gold Nanocage-Photosensitizer Conjugates for Dual-Modal Image-Guided Enhanced Photodynamic Therapy
Srivatsan, A., Jenkins, S. V., Jeon, M., Wu, Z. J., Kim, C., Chen, J., & Pandey, R. K. (2014) · Theranostics · doi:10.7150/thno.7064 · Cited by 123
Environmentally responsive peptides as anticancer drug carriers☆
Aluri, S. R., Janib, S. M., & MacKay, J. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.07.002 · Cited by 119
Kroll, R. A., Pagel, M. A., Muldoon, L. L., Muldoon, L. L., Roman-Goldstein, S., Fiamengo, S. A., Neuwelt, E. A., Neuwelt, E. A., & Neuwelt, E. A. (1998) · Neurosurgery · doi:10.1097/00006123-199810000-00090 · Cited by 118
MMP-2 Protein in Invasive Breast Cancer and the Impact of MMP-2/TIMP-2 Phenotype on Overall Survival
Nakopoulou, L., Tsirmpa, I., Alexandrou, P. T., Louvrou, A., Ampela, C., Markaki, S. P., & Davaris, P. S. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1021371028777 · Cited by 117
Cui, J., Li, C., Guo, W., Li, Y., Wang, C., Zhang, L., Zhang, L., Hao, Y., & Wang, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.002 · Cited by 116
Fattal, E., & BARRATT, G. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00148.x · Cited by 114
Selective gene delivery for cancer therapy using cationic liposomes: In vivo proof of applicability
Dass, C. R., & Choong, P. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.009 · Cited by 114
Photo-Assisted Gene Delivery Using Light-Responsive Catanionic Vesicles
Liu, Y.-C., Le Ny, A.-L. M., Schmidt, J., Talmon, Y., Chmelka, B. F., & Lee, C. T. (2009) · Langmuir · doi:10.1021/la803588d · Cited by 114
Calderón, M., Welker, P., Licha, K., Fichtner, I., Graeser, R., Haag, R., & Kratz, F. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.017 · Cited by 114
Pillay, V., Tsai, T., Choonara, Y. E., du Toit, L. C., Kumar, P., Modi, G., Naidoo, D., Tomar, L. K., Tyagi, C., & Ndesendo, V. M. K. (2014) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34869 · Cited by 114
Remotely Activated Protein-Producing Nanoparticles
Schroeder, A., Goldberg, M. S., Kastrup, C., Wang, Y., Jiang, S., Joseph, B. J., Levins, C. G., Kannan, S. T., Langer, R., & Anderson, D. G. (2012) · Nano Letters · doi:10.1021/nl2036047 · Cited by 113
Rycenga, M., Hou, K. K., Cobley, C. M., Schwartz, A. G., Camargo, P. H. C., & Younan Xia, A. (2009) · Physical Chemistry Chemical Physics · doi:10.1039/b903533h · Cited by 113
Protease‐Triggered Unveiling of Bioactive Nanoparticles
Harris, T. J., von Maltzahn, G., Lord, M. E., Park, J., Agrawal, A., Min, D., Sailor, M. J., & Bhatia, S. N. (2008) · Small · doi:10.1002/smll.200701319 · Cited by 113
Poly(iohexol) Nanoparticles As Contrast Agents for in Vivo X-ray Computed Tomography Imaging
Yin, Q., Yap, F. Y., Yin, L., Ma, L., Zhou, Q., Dobrucki, L. W., Fan, T. M., Gaba, R. C., & Cheng, J. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405196f · Cited by 112
Leo, E., Brina, B., Forni, F., & Vandelli, M. A. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.002 · Cited by 111
Polymere Therapeutika: Konzepte und Anwendungen
Haag, R., & Kratz, F. (2006) · Angewandte Chemie · doi:10.1002/ange.200502113 · Cited by 108
Xiao, Z., Ji, C., Shi, J., Pridgen, E. M., Frieder, J., Wu, J., & Farokhzad, O. C. (2012) · Angewandte Chemie · doi:10.1002/ange.201204018 · Cited by 106
Zhang, Y. S., Wang, Y., Wang, L., Wang, Y., Cai, X., Zhang, C., Wang, L. V., & Younan Xia, A. (2013) · Theranostics · doi:10.7150/thno.5369 · Cited by 106
Self-citationBagalkot, V., & Gao, X. (2011) · ACS Nano · doi:10.1021/nn202772p · Cited by 104
Fleige, G., Seeberger, F., Laux, D., Kresse, M., Taupitz, M., Pilgrimm, H., & Zimmer, C. (2002) · Investigative Radiology · doi:10.1097/00004424-200209000-00002 · Cited by 101
Martín, L., Alonso, M., Girotti, A., Arias, F. J., & Rodríguez‐Cabello, J. C. (2009) · Biomacromolecules · doi:10.1021/bm900560a · Cited by 99
Specific Renal Uptake of Randomly 50% N-Acetylated Low Molecular Weight Chitosan
Yuan, Z.-X., Zhang, Z.-R., Zhu, D., Sun, X., Gong, T., Liu, J., & Luan, C.-T. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800078a · Cited by 99
Shimizu, T., Ichihara, M., Yoshioka, Y., Ishida, T., Nakagawa, S., & Kiwada, H. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00276 · Cited by 96
Indocyanine Green Nanoparticles Useful for Photomedicine
Gomes, A. J., Lunardi, L. O., Marchetti, J. M., Lunardi, C. N., & Tedesco, A. C. (2006) · Photomedicine and Laser Surgery · doi:10.1089/pho.2006.24.514 · Cited by 96
Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review
Montero, A. J., Adams, B., Diaz-Montero, C. M., & Glück, S. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.7 · Cited by 95
Luminescent Gold Nanoparticles with Efficient Renal Clearance
Zhou, C., Long, M., Qin, Y., Sun, X., & Zheng, J. (2011) · Angewandte Chemie · doi:10.1002/ange.201007321 · Cited by 95
Na, K., Lee, E. S., & Bae, Y. H. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070052e · Cited by 94
Dynamics of critical concentration fluctuations in gels
Tanaka, T. (1978) · Physical Review A · doi:10.1103/physreva.17.763 · Cited by 93
Mok, H., Jeong, H., Kim, S.-J., & Chung, B. H. (2012) · Chemical Communications · doi:10.1039/c2cc33555g · Cited by 92
The synthesis of biocompatible and SERS-active gold nanoparticles using chitosan
Potara, M., Maniu, D., & Aştilean, S. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/31/315602 · Cited by 90
Sun, T., Wang, Y., Wang, Y., Xu, J., Zhao, X., Vangveravong, S., Mach, R. H., & Younan Xia, A. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400026 · Cited by 89
Self-citationDelivering cargoes into cancer cells using DNA aptamers targeting internalized surface portals
Orava, E. W., Cicmil, N., & Gariépy, J. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.02.004 · Cited by 89
Novel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment
Mei, L., Zeng, Cheng, Zheng, Song, Huang, & Ma (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s25251 · Cited by 89
Constructing Tunable Nanopores and Their Application in Drug Delivery
Duan, R., Xia, F., & Jiang, L. (2013) · ACS Nano · doi:10.1021/nn405092w · Cited by 88
Zhang, X., Guo, S., Fan, R., Yu, M., Li, F., Zhu, C., & Gan, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.048 · Cited by 87
Application of Polysaccharides for Surface Modification of Nanomedicines
Doh, K., & Yeo, Y. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.105 · Cited by 84
Akita, H., Ishiba, R., Hatakeyama, H., Tanaka, H., Sato, Y., Tange, K., Arai, M., Kubo, K., & Harashima, H. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201200431 · Cited by 83
Chawla, S. P., Chua, V. S., Fernandez, L., Quon, D., Blackwelder, W. C., Gordon, E. M., & Hall, F. L. (2009) · Molecular Therapy · doi:10.1038/mt.2009.228 · Cited by 81
Foerster, C. G., Cursiefen, C., & Kruse, F. E. (2008) · Cornea · doi:10.1097/ico.0b013e318166f483 · Cited by 80
Lee, J., Ahn, J., Park, S. H., Lim, H. Y., Kwon, J. H., Ahn, S., Song, C., Hong, J. H., Kim, C., & Ahn, H. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9757-7 · Cited by 80
A novel microbial infection‐responsive drug release system
Tanihara, M., Suzuki, Y., Nishimura, Y., Suzuki, K., Kakimaru, Y., & Fukunishi, Y. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980418j · Cited by 80
Mass transport enhancement by ultrasound in non-degradable polymeric controlled release systems
Lavon, I., & Kost, J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00112-0 · Cited by 79
Drug delivery strategies using polysaccharidic gels
Coviello, T., Matricardi, P., & Alhaique, F. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.3.395 · Cited by 78
Saltz, L. B., Easley, C., & Kirkpatrick, P. N. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2204 · Cited by 78
Ma, K., Wang, D., Lin, Y., Wang, J., Petrenko, V., & Mao, C. (2013) · Advanced Functional Materials · doi:10.1002/adfm.201102963 · Cited by 77
Acid-transforming polypeptide micelles for targeted nonviral gene delivery
Shim, M. S., & Kwon, Y. J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.019 · Cited by 76
Vose, J. M. (2004) · The Oncologist · doi:10.1634/theoncologist.9-2-160 · Cited by 76
Lee, J., Lee, K., Moon, S. H., Lee, Y., Park, T. G., & Cheon, J. (2009) · Angewandte Chemie · doi:10.1002/ange.200805998 · Cited by 76
Polymer erosion in PLGA microparticles produced by phase separation method
Husmann, M., Schenderlein, S., Lück, M., Lindner, H., & Kleinebudde, P. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00187-4 · Cited by 75
Responsive polymeric delivery systems
Kost, J., & Róbert, L. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90030-g · Cited by 74
In vivo modulation of dendritic cells by engineered materials: Towards new cancer vaccines
Kim, J., & Mooney, D. J. (2011) · Nano Today · doi:10.1016/j.nantod.2011.08.005 · Cited by 72
Lehtinen, J., Magarkar, A., Stȩpniewski, M., Hakola, S., Bergman, M., Róg, T., Yliperttula, M. L., Urtti, A. O., & Bunker, A. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.02.009 · Cited by 72
An enzyme-sensitive probe for photoacoustic imaging and fluorescence detection of protease activity
Xia, X., Yang, M., Oetjen, L. K., Zhang, Y. S., Li, Q., Chen, J., & Younan Xia, A. (2011) · Nanoscale · doi:10.1039/c0nr00874e · Cited by 72
Self-citationTumor‐Targeting Multifunctional Nanoparticles for siRNA Delivery: Recent Advances in Cancer Therapy
Ku, S. H., Kim, K., Choi, K., Kim, S. H., & Kwon, I. C. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300607 · Cited by 71
Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs
Johansen, P., Moon, L., Tamber, H., Merkle, H. P., Gander, B., & Sesardic, D. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00191-7 · Cited by 71
Gold nanocages as multifunctional materials for nanomedicine
Xia, X., & Younan Xia, A. (2013) · Frontiers of Physics · doi:10.1007/s11467-013-0318-8 · Cited by 70
Self-citationLabow, R. S., Meek, E., & Santerre, J. P. (1998) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(19980305)39:3<469::aid-jbm18>3.0.co;2-5 · Cited by 70
Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics
Martinez, J. O., Chiappini, C., Žiemys, A., Faust, A. M., Kojić, M., Liu, X., Mauro Ferrari, B., & Tasciotti, E. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.049 · Cited by 67
Yang, S., Li, N., Chen, D., Qi, X., Xu, Y.-J., Xu, Y., Xu, Q., Li, H., & Lu, J. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20922a · Cited by 66
Integration of in silico and in vitro platforms for pharmacokinetic–pharmacodynamic modeling
Sung, J. H., Esch, M. B., & Shuler, M. L. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2010.496251 · Cited by 64
Zheng, J. N., Xie, H. G., Yu, W. T., Liu, X. D., Xie, W. Y., Zhu, J., & Ma, X. J. (2010) · Langmuir · doi:10.1021/la1030203 · Cited by 64
Techniques for efficient entrapment of pharmaceuticals in biodegradable solid micro/nanoparticles
Ishihara, T., & Mizushima, T. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003713486 · Cited by 63
Smith, W. E., Brownell, J., White, C. C., Afsharinejad, Z., Tsai, J., Hu, X., Polyak, S. J., Gao, X., Kavanagh, T. J., & Eaton, D. L. (2012) · ACS Nano · doi:10.1021/nn302288r · Cited by 61
Zheng, N., Yin, L., Song, Z., Ma, L., Tang, H., Gabrielson, N. P., Lu, H., & Cheng, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.090 · Cited by 59
A Combinatorial Library of Unsaturated Lipidoids for Efficient Intracellular Gene Delivery
Wang, M., Sun, S., Alberti, K. A., & Xu, Q. (2012) · ACS Synthetic Biology · doi:10.1021/sb300023h · Cited by 59
Li, X., Qiu, W., Liu, B., Yao, R., Liu, S., Yao, Y., & Liang, J. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-204 · Cited by 58
Leo, E., Pecquet, S., Rojas, J. M., Couvreur, P., & Fattal, E. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006869 · Cited by 57
Zhao, Y., Dai, D., Lu, C., Chen, L., Lin, M. H., Shen, X.-T., Li, X., Zhang, M., Jiang, X., Jin, R., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.031 · Cited by 57
Smart Materials for Drug Delivery
(2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734318 · Cited by 56
Liu, Y., Wu, D., Zhang, W., Jiang, X., He, C., Chung, T., Goh, S. H., & Leong, K. W. (2005) · Angewandte Chemie · doi:10.1002/ange.200500042 · Cited by 55
Über den Einbau physiologisch wirksamer Substanzen in ein kollodiales Blutplasma-Ersatzmittel
Jatzkewitz, H. (1954) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1954.297.1.149 · Cited by 52
RNA Replicon Delivery via Lipid-Complexed PRINT Protein Particles
Xu, J., Luft, J. C., Yi, X., Tian, S., Owens, G., Wang, J., Johnson, A., Berglund, P., Smith, J., Napier, M. E., et al. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400190z · Cited by 51
Yim, Y. S., Choi, J.-S., Kim, G. T., Kim, C. H., Shin, T.-H., Kim, D. G., & Cheon, J. (2012) · Chem. Commun. · doi:10.1039/c1cc15113d · Cited by 51
SV119-gold nanocage conjugates: a new platform for targeting cancer cellsvia sigma-2 receptors
Wang, Y., Xu, J., Xia, X., Yang, M., Vangveravong, S., Chen, J., Mach, R. H., & Younan Xia, A. (2011) · Nanoscale · doi:10.1039/c1nr11469g · Cited by 50
Self-citationOrnes, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314120110 · Cited by 50
Bouclier, C., Moine, L., Hillaireau, H., Marsaud, V., Connault, E., Opolon, P., Couvreur, P., Fattal, E., & Renoir, J. (2008) · Biomacromolecules · doi:10.1021/bm800664c · Cited by 49
Liposome formulation of a novel hydrophobic aryl-imidazole compound for anti-cancer therapy
Liu, J., Lee, H., Huesca, M., Young, A. H., & Allen, C. J. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0161-x · Cited by 49
Shamsipour, F., Zarnani, A., Ghods, R., Chamankhah, M., Forouzesh, F., Vafaei, S., Bayat, A. A., Akhondi, M. M., Oghabian, M. A., & Jeddi‐Tehrani, M. (2009) · PubMed Central · Cited by 48
(2013) · Methods in molecular biology · doi:10.1007/978-1-62703-541-5 · Cited by 46
Iwase, Y., & Maitani, Y. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100380y · Cited by 42
A Temperature‐Sensitive Drug Release System Based on Phase‐Change Materials
Choi, S., Zhang, Y. S., & Xia, Y. (2010) · Angewandte Chemie · doi:10.1002/ange.201004057 · Cited by 41
Self-citationNanogele als pharmazeutische Trägersysteme: winzige Netzwerke mit großen Möglichkeiten
Kabanov, A. V., & Vinogradov, S. V. (2009) · Angewandte Chemie · doi:10.1002/ange.200900441 · Cited by 40
Dorresteijn, R., Billecke, N., Schwendy, M., Pütz, S., Bonn, M., Parekh, S. H., Klapper, M., & Müllen, K. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201304074 · Cited by 40
Nano Dot Technology Enters Clinical Trials
Friedman, R. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr400 · Cited by 40
Wu, H., Ramanathan, R. K., Zamboni, B. A., Strychor, S., Ramalingam, S. S., Edwards, R. P., Friedland, D., Stoller, R. G., Belani, C. P., Maruca, L. J., et al. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010394851 · Cited by 39
REVIEW OF METAL, CARBON AND POLYMER NANOPARTICLES FOR INFRARED PHOTOTHERMAL THERAPY
Graham, E. G., MacNeill, C. M., & Levi‐Polyachenko, N. H. (2013) · Nano LIFE · doi:10.1142/s1793984413300021 · Cited by 39
Targeted Nanoparticles for Cancer Therapy
Blanco, M. D. V., Teijón, C., Olmo, R., & Teijo, J. M. (2012) · InTech eBooks · doi:10.5772/51382 · Cited by 38
Jatzkewitz, H. (1954) · PubMed · Cited by 38
Effect of Ganciclovir on the Hydrolytic Degradation of Poly(lactide-co-glycolide) Microspheres
Chen, X., Ooi, C. P., & Lim, T. H. (2005) · Journal of Biomaterials Applications · doi:10.1177/0885328206054265 · Cited by 38
Bodmeier, R. A., & McGinity, J. W. (1988) · Journal of Microencapsulation · doi:10.3109/02652048809036729 · Cited by 37
Ultrasound for controlled delivery of therapeutics
Kost, J. (1993) · Clinical Materials · doi:10.1016/0267-6605(93)90103-e · Cited by 37
Ocular adverse effects of Anti-cancer Chemotherapy
Singh, P., & Singh, A. K. (2012) · journal of cancer therapeutics and research · doi:10.7243/2049-7962-1-5 · Cited by 37
Single‐Triggered Trimeric Prodrugs
Haba, K., Popkov, M., Shamis, M., Lerner, R. A., Barbas, C. F., & Shabat, D. (2005) · Angewandte Chemie · doi:10.1002/ange.200461657 · Cited by 37
Hepatology, Principles and Practice: History, Morphology, Biochemistry, Diagnostics, Clinic, Therapy
Kuntz, E., & Kuntz, H.-D. (2001) · Springer eBooks · doi:10.1007/3-540-28977-1 · Cited by 36
Degradation behaviour of self-reinforced 80L/20G PLGA devices in vitro
Välimaa, T., & LAAKSOVIRTA, S. (2003) · Biomaterials · doi:10.1016/j.biomaterials.2003.08.072 · Cited by 35
Zilberman, M., & Grinberg, O. (2007) · Journal of Biomaterials Applications · doi:10.1177/0885328207077591 · Cited by 33
Pan, L., Wang, H., Xie, Z., Li, Z., Tang, X., Xu, Y., Zhang, C., Naranmandura, H., & Chen, S. (2013) · Advanced Materials · doi:10.1002/adma.201301385 · Cited by 31
Blatt, J., Snyderman, C. H., Wollman, M. R., Mirro, J., Janecka, I. P., Albo, V. C., Deutsch, M., Janosky, J. E., & Wiener, E. S. (1997) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(199704)28:4<310::aid-mpo12>3.0.co;2-g · Cited by 29
McCarron, P. A., & Hall, M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.014 · Cited by 29
Chain‐Shattering Polymeric Therapeutics with On‐Demand Drug‐Release Capability
Zhang, Y., Yin, Q., Yin, L., Ma, L., Tang, L., & Cheng, J. (2013) · Angewandte Chemie · doi:10.1002/ange.201300497 · Cited by 28
Self-citationWang, C., Jiang, Y., Chen, L., Li, S., Li, G., & Zhang, Z. (2009) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2009.03.041 · Cited by 27
Transcatheter Arterial Embolization with Zinostatin Stimalamer for Hepatocellular Carcinoma
Okusaka, T., Okada, S., Ueno, H., Ikeda, M., Iwata, R., Furukawa, H., Takayasu, K., Moriyama, N., Sato, T. S., & Sato, K. (2002) · Oncology · doi:10.1159/000059570 · Cited by 26
Integrin αIIbβ3:ligand interactions are linked to binding‐site remodeling
Hantgan, R. R., Stahle, M. C., Connor, J. H., Horita, D. A., Rocco, M., McLane, M. A., Yakovlev, S., & Medved, L. V. (2006) · Protein Science · doi:10.1110/ps.052049506 · Cited by 25
Chung, M., Chen, K., Liang, H., Liao, Z., Chia, W., Younan Xia, A., & Sung, H. (2012) · Angewandte Chemie · doi:10.1002/ange.201205482 · Cited by 23
Yin, L., Tang, H., Kim, K. H., Zheng, N., Song, Z., Gabrielson, N. P., Lu, H., & Cheng, J. (2013) · Angewandte Chemie · doi:10.1002/ange.201302820 · Cited by 23
Emerging Strategies for Controlling Drug Release by Using Visible/Near IR Light
Bio, M., & You, Y. (2013) · Medicinal Chemistry · doi:10.4172/2161-0444.1000138 · Cited by 22
FDA approves liposomal vincristine (Marqibo) for rare leukemia.
Ingram, I. (2012) · PubMed · Cited by 21
Puri, N., Uppada, S. B., Erickson, T., Wojdyla, L. M., Moravec, D. N., Song, Z., & Cheng, J. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s55133 · Cited by 20
Ishii, H. (2003) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyg106 · Cited by 19
Aktuelle Anwendungen für Phasenübergangsmaterialien (PCMs): auch Hans kann noch was lernen!
Hyun, D. C., Levinson, N. S., Jeong, U., & Xia, Y. (2014) · Angewandte Chemie · doi:10.1002/ange.201305201 · Cited by 15
Self-citationBiosensing and Drug Delivery at the Microscale
Robitzki, A. A., & Kurz, R. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_3 · Cited by 13
Jung, K. H., Kim, K., Yoon, D. H., Hong, Y. S., Choi, C., Ahn, J., Lee, D. H., Lee, J., Ryu, M., Ryoo, B., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.e13104 · Cited by 13
Tong, L., Cobley, C. M., Chen, J., Younan Xia, A., & Cheng, J. (2010) · Angewandte Chemie · doi:10.1002/ange.201000440 · Cited by 13
Radiolabeled immunotherapy in non-Hodgkin's lymphoma treatment: the next step
Otte, A., de Wiele, C. V., & Dierckx, R. A. J. O. (2009) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e328313e565 · Cited by 12
Doxorubicin Loaded Polyurethanes Nanoparticles
Dessy, A., Piras, A. M., Alderighi, M., Sandreschi, S., & Chiellini, E. (2012) · Nano Biomedicine and Engineering · doi:10.5101/nbe.v4i2.p83-88 · Cited by 12
Mo, R., Sun, Q., Xue, J., Li, N., Li, W., Zhang, C., & Ping, Q. N. (2012) · Advanced Materials · doi:10.1002/adma.201290167 · Cited by 9
Why not just switch on the light?: light and its versatile applications in the field of nanomedicine
Lehner, R., & Hunziker, P. (2012) · European Journal of Nanomedicine · doi:10.1515/ejnm-2012-0012 · Cited by 8
Abstract 5643: CRLX301, a novel tumor-targeted taxane nanopharmaceutical
Lazarus, D. D., Kabir, S. R., & Eliasof, S. D. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-5643 · Cited by 8
Formulation optimization for high drug loading colonic drug delivery carrier
Wang, Y., Li, P., Kong, L., Peng, Z., & Luo, Y. (2010) · International Conference on Biomedical Engineering and Informatics (BMEI) · doi:10.1109/bmei.2010.5640547 · Cited by 7
Houston Biostartups Strong in Innovation
Potera, C. (2011) · Genetic Engineering & Biotechnology News · doi:10.1089/gen.31.02.20 · Cited by 5
Lu (1999) · doi:10.1002/(sici)1097-4636(199908)46:2
Research works printed but not linked: 30
- Aruna U., 2013, Inter. J. Inn. Pharm. Res., 4, 318
- Langer R., 1998, Nature, 392, 5
- Petre C. E., 2007, Int. J. Nanomed., 2, 277
- Lao J., 2013, J. Drug Delivery, 456409
- Saif M. W., 2007, JOP, 8, 166
- Matsumura Y., 1986, Cancer Res., 46, 6387
- 10.1002/1097-0142(20011115)92:10<2592::AID-CNCR1612>3.0.CO;2-4 · doi:10.1002/1097-0142(20011115)92:10<2592::aid-cncr1612>3.0.co;2-4
- Xu G., 2001, Clin. Cancer Res., 7, 3314
- 10.1016/j.addr.2012.09.008 · doi:10.1016/j.addr.2012.09.008 · Paper page
- Pundir S., 2013, Int. J. Drug Res. Technol., 3, 12
- 10.1021/jp077468 · doi:10.1021/jp077468
- Mohanraj V. J., 2006, J. Pharm. Res., 5, 561
- Ma Y. D., 2011, Int. J. Nanomed., 6, 2679
- 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F · doi:10.1002/(sici)1097-4636(199908)46:2<236::aid-jbm13>3.0.co;2-f
- Krishna R., 2000, Eur. J. Cancer Sci., 11, 265
- Kettiger H., 2013, Int. J. Nanomed., 8, 3255
- Yuan F., 1995, Cancer Res., 55, 3752
- Jain R. K., 1987, Cancer Res., 47, 3039
- 10.1021/nn900002m · DOI · Paper page
- Chidambaram M., 2012, Int. J. Pharm. Sci., 2, 117
- 10.1039/C1CS15237H · DOI · Paper page
- 10.1038/nnano.2007.223 · DOI · Paper page
- Mohanraj V. J., 2006, Trop. J. Pharm. Res., 5, 561
- Hong R. L., 1999, Clin. Cancer Res., 5, 3645
- Shamsipour F., 2009, Avicenna J. Med. Biotechnol., 1, 27
- Park J. W., 2002, Clin. Cancer Res., 8, 1172
- Uppada S. B., 2014, Int. J. Nanomed., 9, 43
- Bangham A. D., 1965, J. Mol. Biol., 13, 227
- Mueller C., 1994, Methods Cell Sci., 16, 183
- 10.1016/j.cbpa.2005.10.005 · DOI
Cited by
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
“A number of nanocarrier-based products have been approved for the treatment of various tumors, and many others are in different phases of clinical trials.(4) In the current review, we first discussed features of different types of nanocarriers (organic, inorganic and hybrid) along with their relevance in cancer therap…”
BackgroundInfluentialLiposomes: Structure, composition, types, and clinical applications
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561
“Liposomes are spherical lipid vesicles (usually 50–500 nm in diameter particle size) composed of one or more lipid bilayers, as a result of emulsifying natural or synthetic lipids in an aqueous medium [12, 13] (Figure 1).”
BackgroundNanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination
Zhang, Y.-N., Poon, W., Tavares, A. J., McGilvray, I. D., & Chan, W. C. W. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.020 · Cited by 1,349
“020 intended target and are sequestered by the liver and spleen (if N6 nm) or eliminated though the kidney (if b6 nm) after administration into the body [2,4].”
BackgroundMethodSelf-citationChallenges and strategies in anti-cancer nanomedicine development: An industry perspective
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,214
Gold Nanomaterials at Work in Biomedicine
Yang, X., Yang, M., Pang, B., Vara, M., & Xia, Y. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00193 · Cited by 1,162
Self-citation
Metadata
- Authors
- Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y.
- Affiliations
- Georgia Institute of Technology (US)
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2014-10-07
- Volume
- 53
- Issue
- 46
- Pages
- 12320-12364
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2134726513
- Cited by
- 2,164
- References
- 578
- Citations by year
- 2026: 57 · 2025: 146 · 2024: 163 · 2023: 153 · 2022: 209 · 2021: 200 · 2020: 221 · 2019: 237 · 2018: 257 · 2017: 230 · 2016: 180 · 2015: 109 · 2014: 2
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Angewandte Chemie International Edition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- engineered nanoparticles, drug delivery, cancer therapy, targeted drug delivery, enhanced permeability and retention effect, pH-responsive delivery, tumor-targeting ligands, tissue distribution, circulation half-life, immunogenicity, combination therapy, multidrug resistance, contrast media, theranostics, nanoparticle surface modification
- MeSH terms
- Animals, Antineoplastic Agents, Delayed-Action Preparations, Humans, Neoplasms, Drug Delivery Systems, Nanotechnology, Nanomedicine, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.